The head of the World Health Organization (WHO), Tedros Adhanom Ghebreyesus, called Pfizer and BioNTech’s announcement on Monday that the vaccine they have jointly developed is 90% effective in preventing coronavirus infections in Phase 3 trials ongoing.
On Twitter, Dr. Tedros said: “We welcome the encouraging vaccine news from @pfizer & @BioNTech_Group and salute all the scientists and partners who are developing new, safe and effective tools to defeat # COVID19.”
A coronavirus vaccine could be launched in March next year for the most vulnerable, which could fundamentally change the course of the Covid-19 pandemic. Reuters he quoted a senior official from the World Health Organization (WHO) on Monday.
Addressing the WHO annual ministerial assembly, Bruce Aylward said the interim results announced earlier in the day from Pfizer Inc’s phase three vaccine trials were “very positive.”
“The ACT Accelerator program, which is a partnership between the World Health Organization, countries like France, and organizations like the World Bank, aims to fundamentally change the direction of the pandemic by March as more tests, treatments and vaccines “. Said the senior adviser to WHO.
‘Extraordinary’ Pfizer Results: Fauci
Anthony Fauci, the US government’s leading infectious disease expert, said the vaccine, developed by Pfizer, to combat the deadly virus will have a “major impact” in the battle against coronavirus.
The effectiveness of Pfizer’s drug candidate exceeding 90% “is simply extraordinary,” Fauci said today while speaking to reporters.
He also said Moderna may have similar results to the Pfizer vaccine because it is also based on mRNA technology, he reports. Bloomberg.
Pfizer’s First Trials Show Vaccine 90% Effective
Earlier today, American drugmaker Pfizer and its German partner BioNTech announced that their Covid-19 vaccine candidate, BNT162b2, has prevented more than 90% of infections in a study of tens of thousands of volunteers in phase 3 trials, the breakthrough most encouraging scientist yet. in the battle against coronavirus.
Pfizer and BioNTech SE became the first drug manufacturers to show successful data from a large-scale clinical trial of a coronavirus vaccine.
The injections by the two companies are among 10 potential candidate vaccines in advanced stage trials worldwide, four of them so far in large studies in the United States.
Pfizer has also reportedly indicated that it is on its way later this month to file an emergency use request with US regulators.
“The mRNA-based candidate vaccine demonstrated evidence of efficacy against COVID-19 in participants without prior evidence of SARS-CoV-2 infection, based on the first interim efficacy analysis conducted on November 8, 2020 by a Monitoring Committee of External and independent data (DMC) from the phase 3 clinical study, “the company said in a statement.
.
